-
-
Item response theory in early phase clinical trials
-
-
Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder
-
-
Perceived barriers and facilitators of structural reimbursement for remote patient monitoring
-
-
Perceived barriers and facilitators of structural reimbursement for remote patient monitoring, an exploratory qualitative study
-
-
FHH quick app review
-
-
A study of novel exploratory tools, digital technologies, and central nervous system biomarkers to characterize unipolar depression
-
-
Characterisation of the pharmacodynamic effects of the P2X7 receptor antagonist JNJ-54175446 using an oral dexamphetamine challenge model in healthy males in a randomised, double-blind, placebo-controlled, multiple ascending dose trial
-
-
The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder (vol 9, 216, 2019)
-
-
The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder
-
-
JNJ-42847922/MIN-202, a selective orexin 2 receptor antagonist, demonstrates beneficial effects on mood and sleep in patients with major depressive disorder
-
-
A biovar-specific signal of Rhizobium leguminosarum bv. viciae induces increased nodulation gene-inducing activity in root exudate of Vicia staiva subsp. nigra
-
-
Cloning and characterization of a gene encoding an outer membrane protein required for siderophore-mediated uptake of Fe3+ in Pseudomonoas putida WCS358
-
-
Accumulation of a nod gene inducer, the flavonoid naringenin, in the cytoplasmic membrane of Rhizobium leguminosarum biovar viceae is caused by the pH-dependent hydrophobicity of naringenin
-
-
Siderophore-mediated uptake of Fe3+ by the plant growth-stimulating Pseudomonas putida strain WCS358 and by other rhizosphere microorganisms